BGP Pharma ULC has posted a notice that DEPAKENE® (valproic acid) capsules (250 mg; DIN 00443840) have been discontinued effective April 24, 2017. https://www.drugshortagescanada.ca/discontinuance/8402
This product has been in shortage since January, so stock levels have been depleted over the past few months. Some pharmacies may still have a small amount on hand but may not be able to replenish what they have. Other pharmacies may already be out-of-stock.
Anyone currently taking Depakene capsules should discuss their treatment options with their healthcare provider. People should work closely with their pharmacist and healthcare provider during the transition from Depakene capsules to an alternate treatment and notify their healthcare provider if they experience side-effects or changes in seizure control.
